Quality is an everyday conversation on the manufacturing floor. Performance measures such as first-pass yield, reject rates, and scrap and rework are displayed on white boards at cells and assembly lines, ruthlessly analyzed and targeted for improvement. Quality tools abound.
Mike Cleland, vice president of NorthHighland, discusses what biotech and pharma companies need to do to comply with new regulations for tracking products throughout the supply chain.
Thirty-six percent of all targeted attacks (58 per day) during the last six months were directed at businesses with 250 or fewer employees, according to the June 2012 Intelligence Report from Symantec. The figure was 18 percent at the end of December 2011.
We like the term "supply chain" because it suggests a tightly interlinked series of steps that results in the uninterrupted flow of product from the raw-materials stage all the way to the consumer. But the word "chain" also evokes a burden, and that's how many companies have come to view their operations in recent years. Hence the mania for outsourcing everything from design and manufacturing to logistics.
Accenture has announced a management consulting contract with Japan's Ministry of Agriculture, Forestry and Fisheries for a project to improve food supply capabilities in natural disasters and emergencies.
Innovation is required if the U.S. is to regain the level of productivity that it enjoyed toward the end of the 19th Century through the mid-20th Century. However, innovation by itself is not enough. Just as our parents and grandparents adopted electricity, the automobile, credit cards and airplanes in the period from 1870-1950, businesses and organizations of the 21st Century must embrace change.
There has been increased interest in the clinical trials supply chain, according to Michael Wallace, life sciences industry specialist with Oracle Corp., and Arun Cavale, principal with NexInfo.
Before Jeff Piccolomini joined Henkel Corp. in 1997, he was dubious about corporate efforts to address environmental concerns - a "typical skeptical CFO," as he puts it. A CPA by training and a longtime finance executive, Piccolomini wasn't accustomed to dealing with the kind of green goals that the German-owned personal-care company had set in motion, such as reducing carbon emissions.
